Apimeds Pharmaceuticals US (APUS) vs FibroBiologics (FBLG)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 10, 2026.
Summary
FibroBiologics is the larger company by market cap ($7.9 million vs $7.6 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | APUS | FBLG |
|---|---|---|
| Share price | $5.02 | $1.13 |
| Market cap | $7.58M | $7.86M |
| 1-day change | -8.89% | +1.80% |
| YTD return | -69.39% | — |
| 1-year return | -73.01% | — |
| EPS (TTM) | $-36.03 | $-5.01 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $59.70 | $9.98 |
| 52-week low | $1.51 | $0.62 |
| Distance from 52-week high | -91.59% | -88.68% |
| Analyst consensus | — | none |
| Avg. price target upside | — | +1006.19% |
| Average volume | 3.67M | 204.44K |
| Shares outstanding | 1.51M | 6.96M |
| Employees | — | 15 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Apimeds Pharmaceuticals US
APUS stock →Apimeds Pharmaceuticals US, Inc. provides digital asset treasury solutions in bitcoin treasury infrastructure.
Health Care · Biotechnology: Pharmaceutical Preparations
About FibroBiologics
FBLG stock →FibroBiologics, Inc., a clinical-stage biotechnology company, engages in the development and commercialization of fibroblast-based therapies for patients suffering from chronic diseases. The company's product pipeline includes CYWC628 which has completed pre-clinical trial for the treatment of wound healing; CYMS101 which has completed Phase 1 trial for the treatment of multiple sclerosis; CybroCell for the treatment of degenerative disc disease; and CYPS317 for the treatment of psoriasis.
Health Care · Biotechnology: Pharmaceutical Preparations · 15 employees
APUS vs FBLG FAQ
Which is bigger, Apimeds Pharmaceuticals US or FibroBiologics?
FibroBiologics (FBLG) is larger, with a market capitalization of $7.86M compared with $7.58M for Apimeds Pharmaceuticals US (APUS).
Are Apimeds Pharmaceuticals US and FibroBiologics in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.